Treating Mucus Hypersecretion in Colds and Influenza
This review covers the role of mucus hypersecretion in the pathogenesis of colds and flu and treatment options for mucus hypersecretion.
This review covers the role of mucus hypersecretion in the pathogenesis of colds and flu and treatment options for mucus hypersecretion.
Amoxicillin unlikely to be clinically effective overall or in specified clinical subgroups in whom antibiotics are commonly prescribed.
Pneumonia prevention interventions such as proper oral care, head-of-bed elevation, and incentive spirometry, are not being provided to most patients outside the ICU, leading to greater than two-thirds of hospital-acquired pneumonia.
Agency is encouraging broader testing for RSV among patients presenting with acute respiratory illness who test negative for COVID-19
Investigators sought to better understand the immunologic mechanisms behind increased susceptibility to secondary respiratory infections.
Household transmission of noninfluenza respiratory viruses are thought to contribute significantly to transmission through the broader community.
In patients with COVID-19 admitted to the ICU with a high acuity of illness and a prolonged period of mechanical ventilation, the time to start rehabilitation was often delayed because of the severity of an individual’s condition.
The findings of a preliminary analysis suggest that COVID-19 may not be characterized by cytokine storm and therefore the benefit of anticytokine therapies remains to be determined.
A patient with a history of achalasia presents to the emergency department with pneumonia that quickly leads to hypoxic respiratory failure.
Patients treated with tocilizumab were 44% less likely to progress to mechanical ventilation or death compared with placebo.